Technetium Tc 99m tilmanocept fails to detect sentinel lymph nodes in endometrial cancer
Background: Technetium Tc 99m tilmanocept is a synthetic radiotracer specifically designed for sentinel lymph node (SLN) mapping that has been FDA-approved in breast cancer, melanoma, and head and neck cancer.No published studies exist for the use of this radiotracer in endometrial cancer.Objective: The primary objective was to determine the detect